Delivery Order SPE2DB20D1004-SPE2DB24FF7K3
Award Date
4/2/24
Potential Completion Date
4/3/24
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $24,581.71 firm-fixed-price delivery order is for the supply of Meloxicam 15 mg tablets. The contract has an ultimate completion date of March 7, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,229.26, is for the delivery of Meloxicam 15 mg tablets. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,269.10, is for the delivery of 180 tablets of the medication Meloxicam 15 mg. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of June 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $6,517.45 and covers the delivery of 4,566,709,125 units of the medication Meloxicam 15 mg tablets. The contract is a Firm Fixed Price Delivery Order with a performance period through December 13, 2024. This award is part of a larger $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of 4,567,249,098 tablets of Meloxicam 15 mg, a generic pharmaceutical drug, to the Defense Logistics Agency (DLA). The firm-fixed-price contract, valued at $94,406.61, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a period of performance through February 13, 2025 and is not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,218.84, is for the delivery of 4,567,362,662 units of Meloxicam 15 mg tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 25, 2025. The award is not designated as a Set-Aside contract....
This federal contract award, with ID SPE2DB24D2105|SPE2DB25FAPKF, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $83,795.68, is a delivery order for 4,567,669,334 units of the prescription drug Meloxicam 15 mg tablet. The contract has a completion date of March 24, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $5,954.53, to provide Meloxicam 7.5 mg tablets to support military healthcare programs. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
This federal contract award, with an ID of SPE2DB22D3004|SPE2DB24FPJ88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 180 tablets of the medication Meloxicam 15 mg, with a ceiling value of $4,978.00 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor on this contract, which is a delivery order under a larger...
This federal contract award, valued at $16,119.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to...